NTI - New International Biosecurity Organization Launched
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: Nuclear Threat Initiative
Relevant to AI safety audiences because IBBIS explicitly addresses how AI/ML amplifies biosecurity risks; represents an institutional governance response to dual-use technology threats analogous to AI governance challenges.
Metadata
Importance: 52/100press releasenews
Summary
NTI launched the International Biosecurity and Biosafety Initiative for Science (IBBIS) in February 2024 as the first independent international organization dedicated solely to biosecurity governance. IBBIS addresses the growing gap between rapid advances in biotechnology—amplified by AI and machine learning—and existing oversight frameworks. The Geneva-based organization aims to provide tools and frameworks enabling responsible innovation while reducing risks of accidental or deliberate misuse of biological agents.
Key Points
- •IBBIS is the first organization solely dedicated to safeguarding modern bioscience tools from deliberate or accidental misuse, headquartered in Geneva.
- •AI and machine learning applied to biotechnology are identified as key risk amplifiers, lowering barriers to manipulating biological agents.
- •Launched at the Munich Security Conference margins on Feb 15, 2024, with NTI's backing and an international advisory group from 13+ countries.
- •Piers Millett Ph.D. serves as inaugural executive director; IBBIS operates independently from NTI with collaborative government partnerships.
- •Aims to fill a critical global governance gap by providing frameworks that allow biotech innovation while reducing catastrophic biological risks.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| IBBIS (International Biosecurity and Biosafety Initiative for Science) | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Apr 7, 20267 KB
New International Biosecurity Organization Launched to Safeguard Bioscience
Close
News
Feb 15, 2024
New International Biosecurity Organization Launched to Safeguard Bioscience
Share
-->
Twitter
Facebook
Linkedin
Email
Links & Downloads
Learn more about IBBIS
Watch the launch event
MUNICH (February 15, 2024)— Amid rapid advances in bioscience and biotechnology that could pose significant global security risks without effective guardrails, the Nuclear Threat Initiative (NTI) today launched the International Biosecurity and Biosafety Initiative for Science (IBBIS), a first-of-its-kind organization to strengthen international biosecurity governance. IBBIS, an independent organization to be headquartered in Geneva, provides tools that will allow technological innovation to flourish, safely and responsibly.
Advances in bioscience offer important societal benefits, but fast-moving innovations have lowered barriers for manipulating biological agents, increasing the risk of potentially catastrophic accidents or deliberate misuse. These risks are exacerbated by the increasing application of artificial intelligence and machine learning to biotechnology.
“Biological threats present a significant global security risk, and the stakes couldn’t be higher,” NTI Co-Chair and CEO Ernest J. Moniz said. “IBBIS was established to create a safer future through collaborative work with governments and international partners to reduce emerging biological risks associated with rapid technology advances.”
Until now, there has been no organization solely dedicated to safeguarding the tools of modern bioscience and biotechnology from deliberate or accidental misuse. NTI identified this gap and worked with international partners to establish IBBIS and launch it today during an event on the margins of the Munich Security Conference. Piers Millett, Ph.D. , serves as the inaugural executive director, and IBBIS has an international advisory group, which includes Nisreen AL-Hmoud from Jordan, Lela Bakanidze from Georgia, Rik Bleijs from the Netherlands, Luis Carrera from the United States, Genya Dana from the United States, O’Neil Hamilton from Jamaica, Aamer Ikram from Pakistan, Angela Kane from Germany, Irma Makalinao from the Philippines, Talkmore Maruta from Zambia, Suryesh Namdeo from India, Harawati Sudoyo from Indonesia, and Weiwen Zhang from China.
IBBIS will collaborate with governments, international organizations, industry and academia to develop and promote practical, innovative tools that stakeholders can use to reduce risks throughout the bioscience and biotechnology research and development lifecycle. The first of such tools is now available—a new Common Mechanism software tool for DNA synthesis providers that enables them to cost effective
... (truncated, 7 KB total)Resource ID:
23767fa4369066e6 | Stable ID: sid_YlSCLA880p